Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Pharmaceutical
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Strength
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Pack Size
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Form
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Source
European Medicines Agency
Safety Profile
Contraindications
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Side Effects
Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Scan this QR code to access this page quickly on your mobile device.